How the AI revolution can accelerate early drug discovery
Drug Target Review
SEPTEMBER 20, 2023
Complex challenges such as metabolic stability or absorption, distribution, metabolism or excretion (ADME) properties could be better predicted, accurately filtering out poor candidates and streamlining discovery. To really benefit from AI, the pharmaceutical industry must be more open to data sharing.
104 
Let's personalize your content